Cite

HARVARD Citation

    Urwyler, P. et al. (2022). Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression. Molecular immunology. pp. 99-113. [Online]. 
  
Back to record